Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates
Alex Laperle, Samuel Sances, Nur Yucer, et al.
Nature Medicine (2020) Vol. 26, Iss. 2, pp. 289-299
Closed Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection
Arun Sharma, Gustavo Garcia, Yizhou Wang, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 4, pp. 100052-100052
Open Access | Times Cited: 296
Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery
Arun Sharma, Samuel Sances, Michael J. Workman, et al.
Cell stem cell (2020) Vol. 26, Iss. 3, pp. 309-329
Open Access | Times Cited: 238
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Jenne Tran, Helena Targa Dias Anastacio, Cédric Bardy
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 143
iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders
Hideyuki Okano, Satoru Morimoto
Cell stem cell (2022) Vol. 29, Iss. 2, pp. 189-208
Open Access | Times Cited: 121
Induced Pluripotent Stem Cells (iPSCs)—Roles in Regenerative Therapies, Disease Modelling and Drug Screening
Mourad A. M. Aboul‐Soud, Alhusain J. Alzahrani, Amer Mahmoud
Cells (2021) Vol. 10, Iss. 9, pp. 2319-2319
Open Access | Times Cited: 105
The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson’s disease
Miao Zhao, Bingwei Wang, Chenyu Zhang, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 8, pp. 2517-2535
Open Access | Times Cited: 59
Parkinson's disease outside the brain: targeting the autonomic nervous system
Yehonatan Sharabi, Gad D. Vatine, Avraham Ashkenazi
The Lancet Neurology (2021) Vol. 20, Iss. 10, pp. 868-876
Closed Access | Times Cited: 57
Hinokitiol functions as a ferroptosis inhibitor to confer neuroprotection
Junmin Xi, Zhijun Zhang, Zuo Wang, et al.
Free Radical Biology and Medicine (2022) Vol. 190, pp. 202-215
Closed Access | Times Cited: 42
Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson’s Disease: A Nationwide Cohort Study
Youngkwon Jo, Seungyeon Kim, Byoung Seok Ye, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41
Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease
Sebastian Schmidt, Malte D. Luecken, Dietrich Trümbach, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Single-cell and single-nuclei RNA sequencing as powerful tools to decipher cellular heterogeneity and dysregulation in neurodegenerative diseases
Raquel Cuevas‐Díaz Durán, Juan Carlos González-Orozco, Iván Velasco, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 38
Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
Satra Nim, Darren M. O’Hara, Carles Corbi‐Verge, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents
Yachao He, Ibrahim Kaya, Mohammadreza Shariatgorji, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
Poojitha Pinjala, Kamatham Pushpa Tryphena, Renuka Prasad, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 25
Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations
G Park, Yeri Alice Rim, Yeowon Sohn, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 6, pp. 1375-1386
Open Access | Times Cited: 15
Stem Cell-Based Therapies for Parkinson Disease
Zhaohui Liu, Hoi‐Hung Cheung
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8060-8060
Open Access | Times Cited: 64
The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
Georgia Minakaki, Dimitri Krainc, Lena F. Burbulla
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 52
Emerging technologies and their impact on regulatory science
Elke Anklam, Martin Iain Bahl, Robert Ball, et al.
Experimental Biology and Medicine (2021) Vol. 247, Iss. 1, pp. 1-75
Open Access | Times Cited: 50
A Practical Approach to Early-Onset Parkinsonism
Giulietta Riboldi, Emanuele Frattini, Edoardo Monfrini, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 1-26
Open Access | Times Cited: 45
Electrophysiological Phenotype Characterization of Human iPSC‐Derived Neuronal Cell Lines by Means of High‐Density Microelectrode Arrays
Silvia Ronchi, Alessio Paolo Buccino, Gustavo Prack, et al.
Advanced Biology (2021) Vol. 5, Iss. 3
Open Access | Times Cited: 44
α-Synuclein mutation impairs processing of endomembrane compartments and promotes exocytosis and seeding of α-synuclein pathology
Morgan G. Stykel, Kayla Humphries, Evelyn Rose Kamski-Hennekam, et al.
Cell Reports (2021) Vol. 35, Iss. 6, pp. 109099-109099
Open Access | Times Cited: 42
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
Jonathan Li, Ryan G. Lim, Julia Kaye, et al.
iScience (2021) Vol. 24, Iss. 11, pp. 103221-103221
Open Access | Times Cited: 41
Induced pluripotent stem cells: a tool for modeling Parkinson’s disease
Anindita Bose, Gregory A. Petsko, Lorenz Studer
Trends in Neurosciences (2022) Vol. 45, Iss. 8, pp. 608-620
Open Access | Times Cited: 33
Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
Xu Hou, T Chen, Shunsuke Koga, et al.
Brain Pathology (2023) Vol. 33, Iss. 5
Open Access | Times Cited: 20
An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases
Shmuel Silnitsky, Samuel J. S. Rubin, Mulate Zerihun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17600-17600
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top